| 000 | 01846 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517071732.0 | ||
| 264 | 0 | _c20160822 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2015.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZuo, Sai-Jie | |
| 245 | 0 | 0 |
_aCombination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cJan 2016 |
||
| 300 |
_a179-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmines _xchemistry |
| 650 | 0 | 4 |
_aAniline Compounds _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aQuinazolines _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 700 | 1 | _aZhang, Sai | |
| 700 | 1 | _aMao, Shuai | |
| 700 | 1 | _aXie, Xiao-Xiao | |
| 700 | 1 | _aXiao, Xue | |
| 700 | 1 | _aXin, Min-Hnag | |
| 700 | 1 | _aXuan, Wei | |
| 700 | 1 | _aHe, Yuan-Yuan | |
| 700 | 1 | _aCao, Yong-Xiao | |
| 700 | 1 | _aZhang, San-Qi | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 24 _gno. 2 _gp. 179-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2015.12.001 _zAvailable from publisher's website |
| 999 |
_c25577230 _d25577230 |
||